A Chinese conglomerate’s acquisition of a US insurer that provided liability coverage to federal intelligence and law enforcement personnel has drawn significant attention from regulators and the insurance sector. In 2015, Fosun Group, a private Chinese company with reported ties to China’s leadership, purchased Wright USA, an insurer known for serving FBI and CIA agents. The deal immediately raised questions in the US about the security of sensitive personal data belonging to intelligence officials.
Jeff Stein, a journalist specialising in intelligence matters, described how he learned of the transaction. “Someone with direct knowledge called me up and said, ‘Do you know that the insurance company that insures intelligence personnel is owned by the Chinese?’” Stein said, as reported by BBC. He emphasised that while the sale was legal and conducted openly, the implications for data security were significant given the close relationship between Chinese business and government interests.
The acquisition was supported by a US$1.2 billion loan from four Chinese state banks, routed through the Cayman Islands, according to data reviewed by the BBC. This financial arrangement highlighted the involvement of Chinese state resources in the transaction.
The sale of Wright USA to a Chinese-owned entity prompted a review by the Committee on Foreign Investment in the United States (CFIUS), which evaluates foreign investments in sectors deemed sensitive to national security. Following the CFIUS inquiry, Wright USA was resold to an American owner, Starr Wright USA. Details of the divestment remain undisclosed.
Senior US intelligence officials have indicated that the Wright USA case was among the factors that led to tighter foreign investment rules in 2018. These regulatory changes increased scrutiny of transactions involving critical industries, including insurance, where access to confidential data is a central concern.
The Wright USA acquisition is part of a broader pattern of Chinese investment in developed economies. AidData, a research lab at William & Mary, has documented that since 2000, Chinese state-backed entities have invested approximately US$2.1 trillion overseas, with a significant share directed at developed countries. Brad Parks, AidData’s executive director, said: “For many years, we assumed that virtually all of China’s money flows were going to developing countries. And so, it came as a great surprise to us when we realised that actually there were hundreds of billions of dollars going into places like the US, the UK, and Germany, happening right underneath our noses.”
These investments align with China’s industrial strategies, most notably the “Made in China 2025” initiative. Launched in 2015, the plan aims to reduce reliance on foreign technology and move China up the global value chain in sectors such as semiconductors, robotics, and biomedicine. The World Economic Forum (WEF) notes that the strategy has evolved: “Today, that strategy appears to be entering a new phase – one we might call ‘Made in China 2.0.’ While it lacks a formal label, its contours are increasingly clear: an AI-augmented, green-energy-powered, self-reliance-oriented transformation of the world’s most formidable industrial base.”
For the insurance sector, the Wright USA case illustrates the intersection of global investment, regulatory oversight, and data security. Insurers with exposure to sensitive client information may face heightened scrutiny in cross-border transactions, particularly as governments respond to evolving geopolitical risks.
As China’s industrial strategy continues to develop, insurance professionals are advised to monitor regulatory trends, assess compliance obligations, and implement robust due diligence in transactions involving sensitive sectors. The changing landscape underscores the importance of transparency and risk management in an increasingly interconnected global market.
